LEADERSHIP FOR THE WORLD'S MOST AMBITIOUS TECHNOLOGIES

Occam Places Natalie Holles as CEO of Aura Biosciences

Occam Recruits Board Director and SAB Member to In Vivo Cell Therapy Leader, Umoja Biopharma

CIO Placed for Global Health Investment Corporation by Occam

AI Leader Recruited for Top Ten Pharma

Key Business Development Executive Placement Expands Occam's Public Biotech Practice

Occam Places CEO Shakti Narayan, JD, PhD for Oncology Biotech Accent Therapeutics

Occam Recruits Ruben Tommasi, PhD as Chief Scientific Officer for Entact Bio

Occam Recruits Human Capital Partner for Prominent Healthcare PE/VC Investor

Occam's Tech Practice Places CRO at Engageli, a Collaborative SW Developer

Occam’s Global Tech Practice Continues to Expand, Placing Daniel Delubac as COO & CTO at Chemify

Occam’s UK Practice Expands, Placing Swati Chatterjee as SVP Sales & Business Development of Chemify

Occam’s European TechBio Practice Accelerates with the Recruitment of Nucleome CEO Mark Bodmer, PhD

Occam’s Board Practice Continues to Flourish

Occam Recruits CEO of Prominent Rare Disease Research Foundation

Occam Places Tim Trost as CFO at Werewolf

Occam Places Richard Beckman as CMO at Adverum

Occam Recruits Sanjeev Luther as President and CEO of Eterna Therapeutics

Occam Places Rabia Gurses Ozden as Board Member at Adverum

Occam Places Radu Dobrin as CTO of Deep Genomics

Occam Places Phil Tagari as CSO at insitro

Occam Places R&D Leader David Mauro as CMO at Recursion

Occam Places Paul Thibodeau as CBO of Hotspot

Occam Places Paul Audhya as CMO of KalVista

Occam Places Juan Estupinan as CFO at Vestaron

Occam Places Nick Pullen as CSO of ARTBIO

Occam Places Kevin Coveney as CFO of Enveric Biosciences

Occam Places John Reynders as Chief Data Sciences Officer of Neumora

Occam Places Jevan Soo Lenox as Chief People Officer at insitro

Occam Places Jeff Goater as Board Chair of AviadoBio

Occam Places Hans Bitter as SVP & Head, Data Sciences at MOMA

Occam Places Jeb Ledell as COO at Aveo Oncology

Occam Places Gurpreet Ratra as CBO at Skyline

Occam Places Geoff McDonough as CEO of Generation Bio

Occam Places Gates Foundation Leader as CEO at Variant Bio

Occam Places General Counsel for Public Biopharma KalVista Pharmaceuticals

Occam Places Eva Jack as COO of Hotspot

Occam Places Gary Glick as Chairman at CHARM Therapeutics

Occam Places Emily Conley as CEO of FederationBio

Occam Places Emily Conley on the Board of Nuvalent

Occam Places Emile Nuwaysir as CEO of Ensoma

Occam Places Sana Hafeez as Head of People at Unlearn

Occam Places Ryan Kelly as Chief Communications Officer at Recursion

Occam Places Matthew Gall as CFO of iTeos Therapeutics

Occam Places Lisa Deschamps as CEO of AviadoBio

Occam Places Dan Kemp as CEO of Shinobi Therapeutics

Occam Places Ed Koval as CBO at Geron

Occam Places John McDonald on Board of Geron

Occam Places Edith Hessel as CSO and Lindsay Edwards as CTO at Relation Therapeutics

Occam Places David Mullarkey as CEO at Bluestar

Occam Places Colin McCracken as CEO at Evonetix

Occam Places Craig Thompson as CEO at Cerevance

Occam Places Chris Haqq as Head of R&D at Elicio Therapeutics

Occam Places CFO for Prominent Swiss Biotech Alentis

Occam Places Bimal Shah as CFO of Corium

Occam Places Carolyn Haley as COO at F-Prime Capital

Occam Global Places CMO of EveryONE Medicines

Occam Recruits Kim Blackwell to Board of NVIDIA-Backed Charm Therapeutics

Occam Recruits CEO for Drug Discovery Platform Company

Occam Recruits CMO for In Vivo Cell Therapy Leader Umoja Biopharma

Occam Recruits Laurent Fischer as Chair of Shinobi Therapeutics

Regulatory Executive Placed by Occam for TechBio Leader Recursion

Occam Recruits Chief Commercial Officer at Geron

Occam Places Prominent Scientific Leader at High Profile Neuro Startup

Occam Recruits Head of BD for Latent Labs

Distinguished Healthcare Leaders Placed on Board of Recursion by Occam

Occam's Strategic Partnership with Geron Continues with the Placement of Head of R&D

Board Recruitment by Occam Global for Clinical Stage Oncology Innovator

Occam’s UK Biotech Practice Accelerates with Placement of CSO at Nucleome

Occam Recruits CRO for Renewable Water Innovator, SOURCE

Occam Recruits Sales and Operations Leader to the Board of Geron

Occam Places Andreas Grauer as CMO at Federation Bio

Occam Recruits Senior Pharma Executive to the Board of Geron

Silicon Valley Leader Placed by Occam Global as CTO of Chemify

Occam Places Chief Legal Officer at Public Oncology Biotech

Occam Places Chief Legal Officer at Public Obesity Biotech, Metsera

CBO Recruited for UK-Based LabGenius by Occam Global

Occam Places CSO of ADC Biotech MBrace Therapeutics

Occam Places Bill Brondyk as CSO at Invetx

Occam Recruits Brent Warner as CEO for Protego Biopharma

Occam Places CEO for RadioPharm Start-Up

Occam Places Jim Burns as CEO of Ensoma

Occam Places Biotech Leader David Southwell as Chairman of Revolo Biotherapeutics

Occam's UK TechBio Recruiting Team Places CCO for Basecamp Research

Annette Matthies as CBO at Elicio Therapeutics

Occam Enhances CytomX's Board with Experienced Physician Executive

CEO of TechBio Platform Company Recruited by Occam Global

Occam's Partnership with LabGenius Endures with the Placement of CSO

Occam's AI Practice Expands with the Recruitment of Dr. Rajiv Patni as Strategic Clinical Advisor to BioXcel Therapeutics

Occam Recruits Translational Leader for Gene Editing Leader Mammoth

CBO Recruited for Leading AIDD Biotech Envisagenics

Occam Recruits Former FDA Commissioner to Faeth Therapeutics

Occam Places Amgen CMO on Board of Moonwalk

Occam Recruits Michael Miller to the Board of BioXcel

Occam Places CEO for Clinical-Stage Immunology Company

Chief Strategy & Financial Officer Recruited to Elicio by Occam Global

Occam Recruits David Moller as Chief Scientific Officer of Variant Bio

Occam Recruits Sapna Srivastava to the Board of Nuvalent

Occam Recruits CSO for Public Gene Therapy Company, Adverum

Occam Recruits Daphne Karydas to the Board of Elicio

Occam Places Wall Street Dynamo and Luminary Leader as CFO at Beam Therapeutics